目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What’s New in This Update?
Scope of Report
Information Sources and Methodology
Research Methodology
Geographic Breakdown

Chapter- 2: Summary and Highlights
Overview
Market Outlook

Chapter- 3: Market and Technology Background
Overview of Human Immunodeficiency Virus (HIV)
Report Overview
HIV Timeline and Milestones
HIV Life Cycle: Treatment and Mechanism of Action
HIV Prophylaxis
Drug Resistance

Chapter- 4: Global Industry Trends
Trends in Global HIV Transmission
Challenges

Chapter- 5: Market Breakdown by HIV Therapeutic
Global Market Forecast for HIV Therapeutics
Regional Markets for HIV Therapeutics
North America
European Market for HIV Therapeutics
Asia-Pacific Market for HIV Therapeutics
Rest of the World (RoW) Market for HIV Therapeutics
Global Investments in the HIV Market

Chapter- 6: HIV Market by ARV Drug Category
Overview
Timeline of Therapies
Market Overview by Drug Category

Chapter- 7: Emerging Technologies
Overview
Molecular Diagnostics
Next-Generation Sequencing (NGS)
Point-of-Care Testing
Artificial Intelligence (AI)
Other Emerging Techniques

Chapter- 8: Evaluation of Market for HIV Diagnostic
Market for HIV Diagnostics by Test Type
Antigen- and Antibody-Based Tests
CD4 Testing
Viral Load Testing
HIV Diagnostic Product Profiles by Test Type

Chapter- 9: Patents
Overview

Chapter- 10: Competitive Landscape
Mergers, Acquisitions and Collaborations

Chapter- 11: Company Profiles
ABBOTT
ASTRAZENECA
B. BRAUN SE
BECTON, DICKINSON AND COMPANY
BIOCON
BIO-RAD LABORATORIES INC.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
DANAHER CORP.
DEXCOM INC.
INSULET CORP.
JOHNSON & JOHNSON SERVICES INC.
LIFESCAN IP HOLDINGS LLC
LILLY
MEDTRONIC
MERCK & CO. INC.
NOVA BIOMEDICAL
NOVARTIS AG
NOVO NORDISK A/S
QIAGEN N.V.
ROCHE (F. HOFFMANN-LA ROCHE LTD.)
SANOFI
SIEMENS HEALTHINEERS AG
TERUMO CORP.
THERMO FISHER SCIENTIFIC INC.
YPSOMED AG